Hamilton Thorne Ltd. has reported the company’s financial results for the quarter ended March 31, 2023. Some financial highlights were: First quarter sales increased 19% to $16.7 million; sales for the quarter increased 24% on a constant currency basis. The first quarter adjusted EBITDA increased 13% to $2.8 million; and fourth quarter EBITDA increased approximately 18% on a constant currency basis. Organic sales growth were up by 15% for the quarter.

Hamilton Thorne Ltd., a client of our Bristol Investor Relations agency, is a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies, research, and cell biology markets.

Read the full press release here: Hamilton Thorne Reports Record Revenue for the Quarter Ended March 31, 2023